Comparative study of vaccine safety surveillance on COVID-19

ABSTRACT

Vaccine among people globally preparations must be made within countries for covid-19 vaccine safety surveillance on an urgent basis. Safety surveillance must be capable of investigating adverse event of special interest (AESI) and adverse event following immunization to determine a change in the benefit-risk profile of the vaccine. COVID-19 vaccine is the most important tool to stem the pandemic. WHO emergency use listing, while using regulatory pathway through national regulatory authorities. Vaccine safety communication plan should be developed. Expending the global vaccine safety system to meet the needs of covid-19 and other emergency and routine use vaccine is a priority currently. The protective efficacy and the short term and long-term side effect of the vaccine are of major concern. Various strategies have been designed the covid-19 pandemic. The highly infectious corona virus disease 2019 associate with me pathogenic severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has spread to become a global pandemic. The development of covid-19 vaccine is crucial for the world to return to pre-pandemic normalcy and the collective global effort has been invested into protective against SARS-CoV2.